Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Seminars in Arthritis and Rheumatism|November 7, 2018
Etanercept concentration and immunogenicity do not influence the response to Etanercept in patients with juvenile idiopathic arthritisBrigitte Bader-Meunier, Roman Krzysiek, Irène Lemelle, et al.
Nucleic Acids Research|March 19, 2011
A method to sequence and quantify DNA integration for monitoring outcome in gene therapyTroy Brady, Shoshannah L Roth, Nirav Malani, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 29, 2008
Restoration of human B-cell differentiation into NOD-SCID mice engrafted with gene-corrected CD34+ cells isolated from Artemis or RAG1-deficient patientsChantal Lagresle-Peyrou, Fatine Benjelloun, Christophe Hue, et al.
Blood|April 15, 2015
Faster T-cell development following gene therapy compared with haploidentical HSCT in the treatment of SCID-X1Fabien Touzot, Despina Moshous, Rita Creidy, et al.
Nature|September 22, 2006
Gene therapy: X-SCID transgene leukaemogenicityAdrian J Thrasher, H Bobby Gaspar, Christopher Baum, et al.
Blood|December 9, 2004
Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trialManfred Schmidt, Salima Hacein-Bey-Abina, Manuela Wissler, et al.
Blood|May 31, 2011
Loss of p19Arf in a Rag1(-/-) B-cell precursor population initiates acute B-lymphoblastic leukemiaJulia Hauer, Charles Mullighan, Estelle Morillon, et al.
Frontiers in Immunology|December 21, 2018
Low Percentage of Signal Regulatory Protein α/β+ Memory B Cells in Blood Predicts Development of Anti-drug Antibodies (ADA) in Adalimumab-Treated Rheumatoid Arthritis PatientsLaura Magill, Marsilio Adriani, Véronique Berthou, et al.
Clinical and Experimental Immunology|April 17, 2021
Long-term exposure to monoclonal anti-TNF is associated with an increased risk of lymphoma in BAFF-transgenic miceGaetane Nocturne, Bineta Ly, Audrey Paoletti, et al.
The New England Journal of Medicine|April 19, 2002
Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapySalima Hacein-Bey-Abina, Françoise Le Deist, Frédérique Carlier, et al.
Pageof 10